daraxonrasib

FDA Drug Profile — RASONQUE

daraxonrasib is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including RASONQUE. Available dosage form: tablet, film coated.

Drug details

Generic Name
daraxonrasib
Brand Names
RASONQUE
Application Number
NDA220910
Sponsor
Revolution Medicines, Inc.
NDC Codes
2
Dosage Forms
TABLET, FILM COATED
Routes
ORAL
Active Ingredients
DARAXONRASIB

Indications and Usage

1 INDICATIONS AND USAGE RASONQUE is indicated for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent systemic therapy. RASONQUE is an inhibitor of the RAS GTPase family, indicated for the treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or who are not candidates for multiagent systemic therapy. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.